Moreover, vaccinia VG9/(SST-14)2-HSA exerted a combined effect including the oncolytic ability provided by the virus and the anti-tumor effect contributed by exogenous (SST-14)2-HSA, and exhibited a higher survival rate than VG9/TK−. The gene discussed is ALB; the disease is neoplasm.